49Z Stock Overview
Operates as a bioconvergence company in North America, Europe, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BICO Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 3.26 |
| 52 Week High | SEK 6.35 |
| 52 Week Low | SEK 2.92 |
| Beta | 2.38 |
| 11 Month Change | -6.04% |
| 3 Month Change | -20.93% |
| 1 Year Change | -26.32% |
| 33 Year Change | -88.82% |
| 5 Year Change | n/a |
| Change since IPO | -63.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 49Z | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 3.6% | 2.2% | 0.2% |
| 1Y | -26.3% | 3.6% | 8.5% |
Return vs Industry: 49Z underperformed the German Life Sciences industry which returned 3.6% over the past year.
Return vs Market: 49Z underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 49Z volatility | |
|---|---|
| 49Z Average Weekly Movement | 8.7% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 49Z's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 49Z's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 832 | Maria Forss | www.bico.com |
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing.
BICO Group AB (publ) Fundamentals Summary
| 49Z fundamental statistics | |
|---|---|
| Market cap | €230.98m |
| Earnings (TTM) | -€130.07m |
| Revenue (TTM) | €210.38m |
1.1x
P/S Ratio-1.8x
P/E RatioIs 49Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 49Z income statement (TTM) | |
|---|---|
| Revenue | SEK 2.42b |
| Cost of Revenue | SEK 684.50m |
| Gross Profit | SEK 1.74b |
| Other Expenses | SEK 3.24b |
| Earnings | -SEK 1.50b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | -21.23 |
| Gross Margin | 71.75% |
| Net Profit Margin | -61.83% |
| Debt/Equity Ratio | 48.6% |
How did 49Z perform over the long term?
See historical performance and comparison